Femoral Head Prostheses Market

ID: MRFR/HC/29495-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Femoral Head Prostheses Market Research Report By Implant Material (Metal-on-Metal, Ceramic-on-Polyethylene, Ceramic-on-Ceramic, Metal-on-Polyethylene), By Application (Primary Total Hip Arthroplasty (THA), Revision Total Hip Arthroplasty, Hip Resurfacing), By Design (Cemented, Uncemented, Hybrid), By Size (Small, Medium, Large, Extra-Large), By End-User (Hospitals, Ambulatory Surgical Centers, Private Orthopedic Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Implant Material (USD Billion)
      1. 4.1.1 Metal-on-Metal
      2. 4.1.2 Ceramic-on-Polyethylene
      3. 4.1.3 Ceramic-on-Ceramic
      4. 4.1.4 Metal-on-Polyethylene
    2. 4.2 Healthcare, BY Application (USD Billion)
      1. 4.2.1 Primary Total Hip Arthroplasty (THA)
      2. 4.2.2 Revision Total Hip Arthroplasty
      3. 4.2.3 Hip Resurfacing
    3. 4.3 Healthcare, BY Design (USD Billion)
      1. 4.3.1 Cemented
      2. 4.3.2 Uncemented
      3. 4.3.3 Hybrid
    4. 4.4 Healthcare, BY Size (USD Billion)
      1. 4.4.1 Small
      2. 4.4.2 Medium
      3. 4.4.3 Large
      4. 4.4.4 Extra-Large
    5. 4.5 Healthcare, BY End-User (USD Billion)
      1. 4.5.1 Hospitals
      2. 4.5.2 Ambulatory Surgical Centers
      3. 4.5.3 Private Orthopedic Clinics
    6. 4.6 Healthcare, BY Region (USD Billion)
      1. 4.6.1 North America
        1. 4.6.1.1 US
        2. 4.6.1.2 Canada
      2. 4.6.2 Europe
        1. 4.6.2.1 Germany
        2. 4.6.2.2 UK
        3. 4.6.2.3 France
        4. 4.6.2.4 Russia
        5. 4.6.2.5 Italy
        6. 4.6.2.6 Spain
        7. 4.6.2.7 Rest of Europe
      3. 4.6.3 APAC
        1. 4.6.3.1 China
        2. 4.6.3.2 India
        3. 4.6.3.3 Japan
        4. 4.6.3.4 South Korea
        5. 4.6.3.5 Malaysia
        6. 4.6.3.6 Thailand
        7. 4.6.3.7 Indonesia
        8. 4.6.3.8 Rest of APAC
      4. 4.6.4 South America
        1. 4.6.4.1 Brazil
        2. 4.6.4.2 Mexico
        3. 4.6.4.3 Argentina
        4. 4.6.4.4 Rest of South America
      5. 4.6.5 MEA
        1. 4.6.5.1 GCC Countries
        2. 4.6.5.2 South Africa
        3. 4.6.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Stryker (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Zimmer Biomet (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 DePuy Synthes (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Smith & Nephew (GB)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Medtronic (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Exactech (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Aesculap (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Waldemar Link (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 B. Braun (DE)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY IMPLANT MATERIAL
    4. 6.4 US MARKET ANALYSIS BY APPLICATION
    5. 6.5 US MARKET ANALYSIS BY DESIGN
    6. 6.6 US MARKET ANALYSIS BY SIZE
    7. 6.7 US MARKET ANALYSIS BY END-USER
    8. 6.8 CANADA MARKET ANALYSIS BY IMPLANT MATERIAL
    9. 6.9 CANADA MARKET ANALYSIS BY APPLICATION
    10. 6.10 CANADA MARKET ANALYSIS BY DESIGN
    11. 6.11 CANADA MARKET ANALYSIS BY SIZE
    12. 6.12 CANADA MARKET ANALYSIS BY END-USER
    13. 6.13 EUROPE MARKET ANALYSIS
    14. 6.14 GERMANY MARKET ANALYSIS BY IMPLANT MATERIAL
    15. 6.15 GERMANY MARKET ANALYSIS BY APPLICATION
    16. 6.16 GERMANY MARKET ANALYSIS BY DESIGN
    17. 6.17 GERMANY MARKET ANALYSIS BY SIZE
    18. 6.18 GERMANY MARKET ANALYSIS BY END-USER
    19. 6.19 UK MARKET ANALYSIS BY IMPLANT MATERIAL
    20. 6.20 UK MARKET ANALYSIS BY APPLICATION
    21. 6.21 UK MARKET ANALYSIS BY DESIGN
    22. 6.22 UK MARKET ANALYSIS BY SIZE
    23. 6.23 UK MARKET ANALYSIS BY END-USER
    24. 6.24 FRANCE MARKET ANALYSIS BY IMPLANT MATERIAL
    25. 6.25 FRANCE MARKET ANALYSIS BY APPLICATION
    26. 6.26 FRANCE MARKET ANALYSIS BY DESIGN
    27. 6.27 FRANCE MARKET ANALYSIS BY SIZE
    28. 6.28 FRANCE MARKET ANALYSIS BY END-USER
    29. 6.29 RUSSIA MARKET ANALYSIS BY IMPLANT MATERIAL
    30. 6.30 RUSSIA MARKET ANALYSIS BY APPLICATION
    31. 6.31 RUSSIA MARKET ANALYSIS BY DESIGN
    32. 6.32 RUSSIA MARKET ANALYSIS BY SIZE
    33. 6.33 RUSSIA MARKET ANALYSIS BY END-USER
    34. 6.34 ITALY MARKET ANALYSIS BY IMPLANT MATERIAL
    35. 6.35 ITALY MARKET ANALYSIS BY APPLICATION
    36. 6.36 ITALY MARKET ANALYSIS BY DESIGN
    37. 6.37 ITALY MARKET ANALYSIS BY SIZE
    38. 6.38 ITALY MARKET ANALYSIS BY END-USER
    39. 6.39 SPAIN MARKET ANALYSIS BY IMPLANT MATERIAL
    40. 6.40 SPAIN MARKET ANALYSIS BY APPLICATION
    41. 6.41 SPAIN MARKET ANALYSIS BY DESIGN
    42. 6.42 SPAIN MARKET ANALYSIS BY SIZE
    43. 6.43 SPAIN MARKET ANALYSIS BY END-USER
    44. 6.44 REST OF EUROPE MARKET ANALYSIS BY IMPLANT MATERIAL
    45. 6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    46. 6.46 REST OF EUROPE MARKET ANALYSIS BY DESIGN
    47. 6.47 REST OF EUROPE MARKET ANALYSIS BY SIZE
    48. 6.48 REST OF EUROPE MARKET ANALYSIS BY END-USER
    49. 6.49 APAC MARKET ANALYSIS
    50. 6.50 CHINA MARKET ANALYSIS BY IMPLANT MATERIAL
    51. 6.51 CHINA MARKET ANALYSIS BY APPLICATION
    52. 6.52 CHINA MARKET ANALYSIS BY DESIGN
    53. 6.53 CHINA MARKET ANALYSIS BY SIZE
    54. 6.54 CHINA MARKET ANALYSIS BY END-USER
    55. 6.55 INDIA MARKET ANALYSIS BY IMPLANT MATERIAL
    56. 6.56 INDIA MARKET ANALYSIS BY APPLICATION
    57. 6.57 INDIA MARKET ANALYSIS BY DESIGN
    58. 6.58 INDIA MARKET ANALYSIS BY SIZE
    59. 6.59 INDIA MARKET ANALYSIS BY END-USER
    60. 6.60 JAPAN MARKET ANALYSIS BY IMPLANT MATERIAL
    61. 6.61 JAPAN MARKET ANALYSIS BY APPLICATION
    62. 6.62 JAPAN MARKET ANALYSIS BY DESIGN
    63. 6.63 JAPAN MARKET ANALYSIS BY SIZE
    64. 6.64 JAPAN MARKET ANALYSIS BY END-USER
    65. 6.65 SOUTH KOREA MARKET ANALYSIS BY IMPLANT MATERIAL
    66. 6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    67. 6.67 SOUTH KOREA MARKET ANALYSIS BY DESIGN
    68. 6.68 SOUTH KOREA MARKET ANALYSIS BY SIZE
    69. 6.69 SOUTH KOREA MARKET ANALYSIS BY END-USER
    70. 6.70 MALAYSIA MARKET ANALYSIS BY IMPLANT MATERIAL
    71. 6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION
    72. 6.72 MALAYSIA MARKET ANALYSIS BY DESIGN
    73. 6.73 MALAYSIA MARKET ANALYSIS BY SIZE
    74. 6.74 MALAYSIA MARKET ANALYSIS BY END-USER
    75. 6.75 THAILAND MARKET ANALYSIS BY IMPLANT MATERIAL
    76. 6.76 THAILAND MARKET ANALYSIS BY APPLICATION
    77. 6.77 THAILAND MARKET ANALYSIS BY DESIGN
    78. 6.78 THAILAND MARKET ANALYSIS BY SIZE
    79. 6.79 THAILAND MARKET ANALYSIS BY END-USER
    80. 6.80 INDONESIA MARKET ANALYSIS BY IMPLANT MATERIAL
    81. 6.81 INDONESIA MARKET ANALYSIS BY APPLICATION
    82. 6.82 INDONESIA MARKET ANALYSIS BY DESIGN
    83. 6.83 INDONESIA MARKET ANALYSIS BY SIZE
    84. 6.84 INDONESIA MARKET ANALYSIS BY END-USER
    85. 6.85 REST OF APAC MARKET ANALYSIS BY IMPLANT MATERIAL
    86. 6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION
    87. 6.87 REST OF APAC MARKET ANALYSIS BY DESIGN
    88. 6.88 REST OF APAC MARKET ANALYSIS BY SIZE
    89. 6.89 REST OF APAC MARKET ANALYSIS BY END-USER
    90. 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. 6.91 BRAZIL MARKET ANALYSIS BY IMPLANT MATERIAL
    92. 6.92 BRAZIL MARKET ANALYSIS BY APPLICATION
    93. 6.93 BRAZIL MARKET ANALYSIS BY DESIGN
    94. 6.94 BRAZIL MARKET ANALYSIS BY SIZE
    95. 6.95 BRAZIL MARKET ANALYSIS BY END-USER
    96. 6.96 MEXICO MARKET ANALYSIS BY IMPLANT MATERIAL
    97. 6.97 MEXICO MARKET ANALYSIS BY APPLICATION
    98. 6.98 MEXICO MARKET ANALYSIS BY DESIGN
    99. 6.99 MEXICO MARKET ANALYSIS BY SIZE
    100. 6.100 MEXICO MARKET ANALYSIS BY END-USER
    101. 6.101 ARGENTINA MARKET ANALYSIS BY IMPLANT MATERIAL
    102. 6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION
    103. 6.103 ARGENTINA MARKET ANALYSIS BY DESIGN
    104. 6.104 ARGENTINA MARKET ANALYSIS BY SIZE
    105. 6.105 ARGENTINA MARKET ANALYSIS BY END-USER
    106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY IMPLANT MATERIAL
    107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY DESIGN
    109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SIZE
    110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER
    111. 6.111 MEA MARKET ANALYSIS
    112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY IMPLANT MATERIAL
    113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY DESIGN
    115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY SIZE
    116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY END-USER
    117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY IMPLANT MATERIAL
    118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY DESIGN
    120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY SIZE
    121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY END-USER
    122. 6.122 REST OF MEA MARKET ANALYSIS BY IMPLANT MATERIAL
    123. 6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION
    124. 6.124 REST OF MEA MARKET ANALYSIS BY DESIGN
    125. 6.125 REST OF MEA MARKET ANALYSIS BY SIZE
    126. 6.126 REST OF MEA MARKET ANALYSIS BY END-USER
    127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. 6.128 RESEARCH PROCESS OF MRFR
    129. 6.129 DRO ANALYSIS OF HEALTHCARE
    130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. 6.133 HEALTHCARE, BY IMPLANT MATERIAL, 2024 (% SHARE)
    134. 6.134 HEALTHCARE, BY IMPLANT MATERIAL, 2024 TO 2035 (USD Billion)
    135. 6.135 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    136. 6.136 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    137. 6.137 HEALTHCARE, BY DESIGN, 2024 (% SHARE)
    138. 6.138 HEALTHCARE, BY DESIGN, 2024 TO 2035 (USD Billion)
    139. 6.139 HEALTHCARE, BY SIZE, 2024 (% SHARE)
    140. 6.140 HEALTHCARE, BY SIZE, 2024 TO 2035 (USD Billion)
    141. 6.141 HEALTHCARE, BY END-USER, 2024 (% SHARE)
    142. 6.142 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion)
    143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.2.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.2.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.2.5 BY END-USER, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.3.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.3.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.3.5 BY END-USER, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.4.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.4.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.4.5 BY END-USER, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.5.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.5.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.5.5 BY END-USER, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.6.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.6.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.6.5 BY END-USER, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.7.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.7.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.7.5 BY END-USER, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.8.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.8.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.8.5 BY END-USER, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.9.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.9.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.9.5 BY END-USER, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.10.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.10.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.10.5 BY END-USER, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.11.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.11.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.11.5 BY END-USER, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.12.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.12.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.12.5 BY END-USER, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.13.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.13.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.13.5 BY END-USER, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.14.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.14.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.14.5 BY END-USER, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.15.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.15.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.15.5 BY END-USER, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.16.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.16.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.16.5 BY END-USER, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.17.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.17.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.17.5 BY END-USER, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.18.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.18.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.18.5 BY END-USER, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.19.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.19.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.19.5 BY END-USER, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.20.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.20.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.20.5 BY END-USER, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.21.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.21.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.21.5 BY END-USER, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.22.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.22.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.22.5 BY END-USER, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.23.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.23.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.23.5 BY END-USER, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.24.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.24.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.24.5 BY END-USER, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.25.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.25.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.25.5 BY END-USER, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.26.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.26.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.26.5 BY END-USER, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.27.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.27.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.27.5 BY END-USER, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.28.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.28.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.28.5 BY END-USER, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.29.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.29.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.29.5 BY END-USER, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY IMPLANT MATERIAL, 2025-2035 (USD Billion)
      2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
      3. 7.30.3 BY DESIGN, 2025-2035 (USD Billion)
      4. 7.30.4 BY SIZE, 2025-2035 (USD Billion)
      5. 7.30.5 BY END-USER, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Femoral Head Prostheses Market Segmentation

Femoral Head Prostheses Market By Implant Material (USD Billion, 2025-2035)

  • Metal-on-Metal
  • Ceramic-on-Polyethylene
  • Ceramic-on-Ceramic
  • Metal-on-Polyethylene

Femoral Head Prostheses Market By Application (USD Billion, 2025-2035)

  • Primary Total Hip Arthroplasty (THA)
  • Revision Total Hip Arthroplasty
  • Hip Resurfacing

Femoral Head Prostheses Market By Design (USD Billion, 2025-2035)

  • Cemented
  • Uncemented
  • Hybrid

Femoral Head Prostheses Market By Size (USD Billion, 2025-2035)

  • Small
  • Medium
  • Large
  • Extra-Large

Femoral Head Prostheses Market By End-User (USD Billion, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Private Orthopedic Clinics